Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.
Gipson, Debbie S
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. [electronic resource] - Kidney international Mar 2011 - 678-685 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1523-1755
10.1038/ki.2010.485 doi
Administration, Oral
Adolescent
Adult
Chi-Square Distribution
Child
Child, Preschool
Dexamethasone--administration & dosage
Drug Resistance
Drug Therapy, Combination
Female
Glomerular Filtration Rate
Glomerulosclerosis, Focal Segmental--complications
Humans
Immunosuppressive Agents--administration & dosage
Male
Mycophenolic Acid--administration & dosage
Prospective Studies
Proteinuria--drug therapy
Pulse Therapy, Drug
Quality of Life
Regression Analysis
Research Design
Surveys and Questionnaires
Time Factors
Treatment Outcome
United States
Young Adult
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. [electronic resource] - Kidney international Mar 2011 - 678-685 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
1523-1755
10.1038/ki.2010.485 doi
Administration, Oral
Adolescent
Adult
Chi-Square Distribution
Child
Child, Preschool
Dexamethasone--administration & dosage
Drug Resistance
Drug Therapy, Combination
Female
Glomerular Filtration Rate
Glomerulosclerosis, Focal Segmental--complications
Humans
Immunosuppressive Agents--administration & dosage
Male
Mycophenolic Acid--administration & dosage
Prospective Studies
Proteinuria--drug therapy
Pulse Therapy, Drug
Quality of Life
Regression Analysis
Research Design
Surveys and Questionnaires
Time Factors
Treatment Outcome
United States
Young Adult